This led us to investigate whether a curated urothelial in vitro IFNγ-response gene set applied to the unsupervised clustering of bladder cancer cohorts to yield an “IFNγ-signature” score would be more informative of tumour IFNγ response. This evidence concerns the gene IFNG and neoplasm.